AFT Pharmaceuticals Brings Next-Generation Liposomal Collagen and Wellness Range to the U.S. Market
Thursday, November 20, 2025
New range reflects rising demand for clinically driven self-care solutions
AUCKLAND, New Zealand, Nov. 12, 2025 /PRNewswire/ -- AFT Pharmaceuticals, a leader in innovative health solutions, today announced the launch of its full family of Lipo-Sachets(®) products in the United States. The new lineup brings cutting-edge liposomal delivery technology to everyday health and beauty routines, making it easier for consumers to look and feel their best.
The range introduces two advanced collagen formulations designed for real-life results. Age Repair Lipo-Sachets(®) combines marine collagen peptides with Vitamins C, E, A and Biotin to support smoother-looking skin, stronger hair and nails, and improved elasticity and firmness. Clinical research backs these benefits: in a 12-week placebo-controlled study, daily collagen supplementation reduced crow's feet wrinkles by 16.5% with visible improvement in nearly three-quarters of participants, while also delivering measurable gains in skin firmness and elasticity by weeks 8 and 12.(1)
For mobility and long-term joint comfort, Super Joint Lipo-Sachets(®) delivers a comprehensive joint health solution. The formula blends marine collagen peptides with Glucosamine and Chondroitin to help maintain cartilage strength and flexibility, while Vitamins C, D and E support bone health, muscle function and antioxidant protection. Taken daily, it's designed to ease stiffness, support mobility and keep people moving comfortably at every stage of life.
To round out the offering, AFT is also launching a liposomal vitamin collection that includes Vitamin C, Vitamin D and Iron. Powered by the same patented LIPOSHELL(®) technology, these supplements are designed for superior absorption and effectiveness compared to traditional formats, giving consumers a reliable way to support daily wellness.
"We are excited to bring our liposomal technology and wellness innovations to the United States," said Dr. Hartley Atkinson, Managing Director at AFT Pharmaceuticals. "Consumers here are looking for products that are clean, effective and backed by science. By combining advanced delivery systems with high-quality ingredients, we aim to deliver visible beauty and mobility benefits that traditional formats cannot match."
The patented Liposhell delivery system works by encapsulating nutrients in microscopic liposomes that mimic the body's cellular structure. This protective layer allows vitamins and collagen peptides to pass safely through the digestive system and reach the bloodstream intact. The result is better absorption, fewer digestive upsets and benefits that can be seen and felt, from glowing skin to stronger joints and everyday energy.
AFT Pharmaceuticals has already seen strong demand for its Lipo-Sachets(®) in New Zealand, Australia and Asia. With the U.S. launch, the company is set to meet growing interest in high-quality supplements that combine science with convenience.
The collagen line, including Age Repair and Super Joint, will be available through Amazon.com starting at $59.99 per 30-day supply, while the vitamin range, featuring Vitamin C, Vitamin D and Iron, will be offered starting at $29.99 per 30-day supply.
For more information, please visit aftpharm.com.
About AFT Pharmaceuticals
AFT is a growing New Zealand-based multinational pharmaceutical company that develops, markets, and distributes a broad portfolio of pharmaceutical products across a wide range of therapeutic categories, which are distributed across all major pharmaceutical distribution channels: over the counter (OTC), prescription and hospital. Our product portfolio comprises both proprietary and in-licensed products, and includes patented, branded, and generic drugs. Our business model is to develop and in-license products for our markets of Australia, New Zealand, Singapore, Malaysia, Hong Kong, USA, Canada, EU ex Ireland and UK, and to out-license our products to local licensees and distributors to over 125 countries around the world. For more information about the company, visit our website www.aftpharm.com.
(Source: 1. Duteil L, et, al. JOJ Case Stud. 2018; 6(4): 555692. DOI: 10.19080/JOJCS.2018.06.555692)
View original content to download multimedia:https://www.prnewswire.com/news-releases/aft-pharmaceuticals-brings-next-generation-liposomal-collagen-and-wellness-range-to-the-us-market-302612533.html
SOURCE AFT Pharmaceuticals
|
|
|
|
|
 |
Call for entries: Canadian Journalism Foundation awards and fellowships | Jan 22, 2026
|
|
Virtana First to Extend Agentic AI Across Every Axis of the Enterprise Stack | Jan 22, 2026
|
|
From Content Complexity to Connected Retailing: 7 Transformations Redefining Travel in 2026 -- Led by the Rise of Agentic AI | Jan 22, 2026
|
|
Residential Home Health and Hospice Named 2025 Best Place to Work in PA | Jan 22, 2026
|
|
The9 Limited Announces Result of Annual General Meeting | Jan 22, 2026
|
|
Evertune Launches Topic Relevance and Brand Relevance: New Metrics Reveal Which Content Sources Actually Influence AI's Brand Perceptions | Jan 22, 2026
|
|
TGE's APPLICATION FOR LISTING ON THE LONDON STOCK EXCHANGE AND PUBLICATION OF PROSPECTUS | Jan 22, 2026
|
|
Brandi AI Wins 2025 Intellyx Digital Innovator Award | Jan 22, 2026
|
|
pcc Practice Builder(TM) Emerges as a Growth Engine for Medical Practices in 2026 | Jan 22, 2026
|
|
Commercial Refrigeration Market worth $67.31 billion by 2030 - Exclusive Report by MarketsandMarkets(TM) | Jan 22, 2026
|
|
|
